P

Inventor

LIU QIHONG

CN11 patents
⚠️ This page may combine multiple inventors who share the name “LIU QIHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHANGHAI FOCHON PHARMACEUTICAL CO LTD

6 patents
US9556171B2Jan 31, 2017

Certain protein kinase inhibitors

SHANGHAI FOCHON PHARMACEUTICAL CO LTD2 citations70
US10087195B2Oct 2, 2018

Certain protein kinase inhibitors

SHANGHAI FOCHON PHARMACEUTICAL CO LTD2 citations60
US11168078B2Nov 9, 2021

Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase

SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations50
US10894038B2Jan 19, 2021

Indolizine derivatives, composition and methods of use

SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations49
US10022374B2Jul 17, 2018

Certain protein kinase inhibitors

SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations49
US10328060B2Jun 25, 2019

Certain protein kinase inhibitors

SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations38

LAUDERDALE II ROBERT P

2 patents
US8687494B2Apr 1, 2014

System and method for Ec/Io access screening in a CDMA network

LAUDERDALE II ROBERT P2 citations56
US8159951B2Apr 17, 2012

System and method for Ec/Io access screening in a CDMA network

LAUDERDALE II ROBERT P2 citations56

FOCHON BIOSCIENCES LTD

2 patents
US11555042B2Jan 17, 2023

Macrocyclic compounds as TRK kinases inhibitors

FOCHON BIOSCIENCES LTD0 citations43
US11459332B2Oct 4, 2022

Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors

FOCHON BIOSCIENCES LTD0 citations43

CHONGQING FOCHON PHARMACEUTICAL CO LTD

1 patent
US10450316B2Oct 22, 2019

Certain protein kinase inhibitor

CHONGQING FOCHON PHARMACEUTICAL CO LTD0 citations32